|
⚲
|
| Keyboard |
| RedCo II Master Fund LP
✚
|
|
|---|---|
| CIK # | 0001921783 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001921783] | |
| 4 | [0001921783] | |
| SC 13G | [0001921783] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Redco II Master Fund LP | Gritstone Bio Inc | [2024-10-07] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2025-10-27 | Buy | 3,846,153 | $3.90 | 14,999,997 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2025-10-27 | Buy | 3,846,153 | $3.90 | 14,999,997 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2025-06-11 | Buy | 12,465,234 | $3.43 | 42,755,753 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2025-06-11 | Buy | 15,734,267 | $3.43 | 53,968,536 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-11 | Buy | 50,000 | $2.28 | 114,000 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-11 | Buy | 50,000 | $3.81 | 190,500 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-11 | Buy | 50,000 | $3.81 | 190,500 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-11 | Buy | 50,000 | $2.28 | 114,000 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-04 | Other | 50,672 | $2.07 | 104,891 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2024-12-04 | Other | 26,656 | $2.07 | 55,178 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2024-12-04 | Other | 26,656 | $2.07 | 55,178 |
|
ADC Therapeutics SA ADCT
Pre-Funded Warrants · derivative
|
2024-12-04 | Other | 26,656 | $2.07 | 55,178 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-04 | Other | 50,672 | $2.07 | 104,891 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-04 | Sell | 25,352 | $2.07 | 52,479 |
|
ADC Therapeutics SA ADCT
Common Shares, par value CHF 0.08 per share
|
2024-12-04 | Other | 50,672 | $2.07 | 104,891 |
|
Malo Holdings Corp AUGX
Common Stock
|
2024-10-02 | Disposed to issuer | 9,446,146 | $2.35 | 22,198,443 |
|
Malo Holdings Corp AUGX
Breakeven Warrants · derivative
|
2024-10-02 | Disposed to issuer | 1,093,799 | ||
|
Malo Holdings Corp AUGX
Breakeven Warrants · derivative
|
2024-10-02 | Disposed to issuer | 1,093,799 | ||
|
Malo Holdings Corp AUGX
Pre-Funded Warrants to Purchase Common Stock · derivative
|
2024-10-02 | Disposed to issuer | 3,125,195 | ||
|
Malo Holdings Corp AUGX
Pre-Funded Warrants to Purchase Common Stock · derivative
|
2024-10-02 | Disposed to issuer | 3,125,195 | ||
| showing 20 of 60 most recent transactions | |||||